<DOC>
	<DOCNO>NCT02687763</DOCNO>
	<brief_summary>A prospective , multisite study evaluate Impact Measles , Mumps , Rubella Varicella ProQuad® vaccination pediatric patient 6-24 month age consider and/or evaluate solid organ transplant ( heart , liver kidney )</brief_summary>
	<brief_title>Safety Efficacy ProQuad® Children 6-24 Month Being Evaluated Solid Organ Transplant</brief_title>
	<detailed_description>Primary Aim : To measure antibody response ProQuad® vaccination give earlier current recommended age patient age 6 month 24 month consider and/or evaluate solid organ transplant ( heart , liver kidney ) within next five year . These subject would reach recommended age receive vaccine transplant . Hypothesis : The Investigator propose hypothesis propose study population mount clinically significant response two ( 2 ) dos ProQuad® vaccine . Primary Endpoint : With respect expect outcomes , work propose expect provide tool optimize ProQuad® vaccination strategy population . Secondary Aim : To determine safety ProQuad® vaccination child age 6 month 24 month consider and/or evaluate solid organ transplant ( heart , liver , kidney ) . Hypothesis : The Investigator propose hypothesis study population similar safety profile compare child receive vaccine recommend age . Secondary Endpoint : The secondary outcome measure represent child study either adverse effect minimal adverse effect ProQuad® vaccine . Adverse effect monitor via Electronic Medical Records ( EMR ) Emergency Department ( ED ) , hospital clinic visit , follow-up phone call family/subjects , well vaccination report card parents/legal guardian participant study complete child 7 day he/she receive dose vaccine .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Liver Failure , Acute</mesh_term>
	<criteria>1 . Parent and/or legal guardian willing able give inform consent . 2 . Patients 6 month 24 month age consider and/or evaluate solid organ transplant within next five ( 5 ) year willing : receive two dos ProQuad® least 30 day 365 day apart . participate three ( 3 ) antibody titer blood draw . 1 . History allergy vaccine component , bleed disorder , exposure measles , mumps , rubella , varicella , zoster 30 day prior vaccination . 2 . Receipt blood product immunoglobulin receive previous 180 day prior vaccination . 3 . Previously receive measles , mumps , rubella and/or varicella vaccine either alone combination prior vaccination . 4 . Any condition cause investigator determine subject appropriate enroll .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>vaccine</keyword>
	<keyword>ProQuad</keyword>
	<keyword>immunosuppressed</keyword>
	<keyword>solid organ transplant</keyword>
	<keyword>MMRV</keyword>
</DOC>